Skip to the page

Data / Drug companies / Tapi Croatia Industries Ltd.

Tapi Croatia Industries Ltd.: 36 products in the FDA NDC directory, labeler code 11722

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Tapi Croatia Industries Ltd. (labeler code 11722) lists 36 products in the FDA National Drug Code Directory. By type: 36 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 25, 2026.

The request: Watch Tapi Croatia Industries Ltd. (FDA labeler code 11722): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
11722
Products in commercial distribution
36
Packages
36
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule IV 2
Started marketing in the last 12 months
1
Earliest marketing start
April 23, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients36100%

Products by type

TypeProductsShare
Bulk ingredients36100%

Dosage forms

Dosage formProductsShare
Powder36100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Brexpiprazole11722-085PowderBulk ingredientsFebruary 25, 2026
Betamethasone acetate11722-084PowderBulk ingredientsOctober 17, 2025
Zavegepant11722-083PowderBulk ingredientsDecember 16, 2024
Tafamidis meglumine11722-082PowderBulk ingredientsDecember 16, 2024
Tafamidis11722-081PowderBulk ingredientsDecember 16, 2024
Nilotinib tartrate11722-075PowderBulk ingredientsFebruary 7, 2024
Neratinib maleate11722-079PowderBulk ingredientsMay 15, 2023
Omeprazole11722-053PowderBulk ingredientsDecember 13, 2022
Saxagliptin11722-078PowderBulk ingredientsNovember 1, 2021
Risedronate sodium11722-077PowderBulk ingredientsJuly 20, 2021
Eltrombopag olamine11722-051PowderBulk ingredientsJuly 16, 2021
Timolol maleate11722-076PowderBulk ingredientsApril 29, 2021
Elagolix sodium11722-074PowderBulk ingredientsMarch 23, 2021
Eltrombopag choline11722-071PowderBulk ingredientsAugust 26, 2019
Nilotinib fumarate11722-070PowderBulk ingredientsAugust 26, 2019
Dasatinib monohydrate11722-069PowderBulk ingredientsAugust 26, 2019
Sugammadex sodium11722-068PowderBulk ingredientsMay 21, 2019
Diroximel fumarate11722-067PowderBulk ingredientsMay 22, 2018
Crisaborole11722-066PowderBulk ingredientsMarch 1, 2018
Deferasirox11722-040PowderBulk ingredientsDecember 11, 2017
Azithromycin dihydrate11722-042PowderBulk ingredientsDecember 7, 2017
O-desvenlafaxine succinate11722-023PowderBulk ingredientsNovember 21, 2017
Etodolac micronized11722-064PowderBulk ingredientsJanuary 18, 2017
Fluvoxamine maleate11722-063PowderBulk ingredientsAugust 23, 2016
Apremilast11722-062PowderBulk ingredientsMay 10, 2016

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.